The evidence for primary axonal loss in multiple sclerosis

The evidence for primary axonal loss in multiple sclerosis

Mostra altre versioni (1)

Introduction. At what stage in the pathogenesis of multiple sclerosis (MS) does the damage to axons occur, and why should there be any axon loss at all in what is thought to be principally an axon sparing demyelinating disease? A recently described new technique for investigating axon damage depends...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Anthony, D, Hughes, P, Perry, V
Natura:	Journal article
Lingua:	Spanish; Castilian
Pubblicazione:	2000

Documenti analoghi

[The evidence for primary axonal loss in multiple sclerosis]
di: Anthony, D, et al.
Pubblicazione: (2000)

Axon damage and repair in multiple sclerosis.
di: Perry, V, et al.
Pubblicazione: (1999)

The contribution of demyelination to axonal loss in multiple sclerosis
di: DeLuca, G, et al.
Pubblicazione: (2006)

The contribution of demyelination to axonal loss in multiple sclerosis.
di: DeLuca, G, et al.
Pubblicazione: (2006)

Axonal loss in the optic nerve and tract in multiple sclerosis
di: Esiri, M, et al.
Pubblicazione: (2000)

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
di: Evangelou, N, et al.
Pubblicazione: (2000)

Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.
di: Lee, M, et al.
Pubblicazione: (2000)

Axonal Damage in Pediatric Multiple Sclerosis
di: Nancy L Kuntz
Pubblicazione: (2015-05-01)

Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.
di: DeLuca, G, et al.
Pubblicazione: (2004)

Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis.
di: Reddy, H, et al.
Pubblicazione: (2000)

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis.
di: Evangelou, N, et al.
Pubblicazione: (2000)

Protein co-expression with axonal injury in multiple sclerosis plaques.
di: Diaz-Sanchez, M, et al.
Pubblicazione: (2006)

COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis
di: Susana Sainz de la Maza, et al.
Pubblicazione: (2024-08-01)

The role of axonal pathology in MS disability
di: Perry, V, et al.
Pubblicazione: (1999)

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis
di: Parry, A, et al.
Pubblicazione: (2002)

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
di: Parry, A, et al.
Pubblicazione: (2003)

Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy.
di: Blamire, A, et al.
Pubblicazione: (2007)

EVIDENCE OF SUBCORTICAL ATROPHY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
di: Arun, T, et al.
Pubblicazione: (2009)

Detection of anti-Myalin and anti-axonal auto-antibodies in Iraqi patients with multiple sclerosis
di: Rasha Majid Abdulamir Al-hemiary
Pubblicazione: (2013-01-01)

T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases.
di: Newman, T, et al.
Pubblicazione: (2001)

Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability.
di: De Stefano, N, et al.
Pubblicazione: (2002)

In vivo evidence for cell body loss in cortical lesions in people with multiple sclerosis
di: Eva A. Krijnen, et al.
Pubblicazione: (2025-01-01)

Targeting SMOX Preserves Optic Nerve Myelin, Axonal Integrity, and Visual Function in Multiple Sclerosis
di: Harry O. Henry-Ojo, et al.
Pubblicazione: (2025-01-01)

Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
di: Coles, A, et al.
Pubblicazione: (2003)

Evidence for genetic basis of multiple sclerosis
di: Sadovnick, A, et al.
Pubblicazione: (1996)

Grey matter neuronal loss in multiple sclerosis
di: Cifelli, A, et al.
Pubblicazione: (2002)

ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride
di: Arun, T, et al.
Pubblicazione: (2013)

A translational MRI approach to validate acute axonal damage detection as an early event in multiple sclerosis
di: Antonio Cerdán Cerdá, et al.
Pubblicazione: (2024-01-01)

Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride
di: Arun, T, et al.
Pubblicazione: (2013)

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
di: Arun, T, et al.
Pubblicazione: (2013)

CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis
di: Benjamin D.S. Clarkson, et al.
Pubblicazione: (2023-11-01)

Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis.
di: Kerschensteiner, M, et al.
Pubblicazione: (2004)

Assessment of axonal injury in multiple sclerosis: combined analysis of serum light-chain neurofilaments and diffusion tensor imaging
di: Mohammadreza Sharifi, et al.
Pubblicazione: (2024-12-01)

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.
di: Wegner, C, et al.
Pubblicazione: (2006)

Primary biliary cirrhosis and multiple sclerosis.
di: Noseworthy, J, et al.
Pubblicazione: (1989)

Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.
di: Anthony, D, et al.
Pubblicazione: (1997)

Evidence for a multiple sclerosis epidemic?
di: Krone, B, et al.
Pubblicazione: (2012)

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model
di: Vergo, S, et al.
Pubblicazione: (2011)

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
di: Vergo, S, et al.
Pubblicazione: (2011)

Pineal gland volume loss in females with multiple sclerosis
di: Miloš Vuković, et al.
Pubblicazione: (2024-05-01)